Patents by Inventor Tal Gefen

Tal Gefen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240002957
    Abstract: The present disclosure provides devices, systems, kits and methods for rapid, simple self-sampling and self-performing detection of nucleic acid sequence of interest in a sample, specifically, nucleic acid sequences of pathogenic agents.
    Type: Application
    Filed: May 13, 2021
    Publication date: January 4, 2024
    Inventors: Naama GEVA-ZATORSKY, Nadav BEN-ASSA, Rawi NADDAF, Tal GEFEN
  • Publication number: 20230076434
    Abstract: The present invention, in some embodiments thereof, is directed to a method for isolating a target microorganism from a sample, including contacting a sample with an antibody having specific affinity to the target microorganism, wherein the antibody is produced by immunizing a host organism using a selected target microorganism, wherein the selected target microorganism is selected by contacting the sample with one or more polynucleotide molecules each having specific affinity to one target microorganism, and determining the presence of the target microorganism in the sample.
    Type: Application
    Filed: February 3, 2021
    Publication date: March 9, 2023
    Inventors: Naama GEVA-ZATORSKY, Tal GEFEN
  • Publication number: 20210023217
    Abstract: A protein, e.g. an antibody, coated with a non-immunogenic molecule selected from an amino-monosaccharide-biotin adduct or a monosaccharide-biotin adduct is disclosed, wherein the coated protein, which has diminished immunogenicity relative to the uncoated protein and intact biological activity, enables, for example, cross-species vaccination.
    Type: Application
    Filed: October 11, 2020
    Publication date: January 28, 2021
    Inventors: Jacob PITCOVSKI, Jacob VAYA, Soliman KHATIB, Elina AIZENSHTEIN, Tal GEFEN
  • Patent number: 10821179
    Abstract: A protein, e.g. an antibody, coated with a non-immunogenic molecule selected from an amino-monosaccharide-biotin adduct or a monosaccharide-biotin adduct is disclosed, wherein the coated protein, which has diminished immunogenicity relative to the uncoated protein and intact biological activity, enables, for example, cross-species vaccination.
    Type: Grant
    Filed: November 4, 2015
    Date of Patent: November 3, 2020
    Assignee: GAVISH-GALILEE BIO APPLICATIONS, LTD.
    Inventors: Jacob Pitcovski, Jacob Vaya, Soliman Khatib, Elina Aizenshtein, Tal Gefen
  • Publication number: 20160120977
    Abstract: A protein, e.g. an antibody, coated with a non-immunogenic molecule selected from an amino-monosaccharide-biotin adduct or a monosaccharide-biotin adduct is disclosed, wherein the coated protein, which has diminished immunogenicity relative to the uncoated protein and intact biological activity, enables, for example, cross-species vaccination.
    Type: Application
    Filed: November 4, 2015
    Publication date: May 5, 2016
    Applicant: GAVISH-GALILEE BIO APPLICATIONS, LTD.
    Inventors: Jacob Pitcovski, Jacob Vaya, Soliman Khatib, Elina Aizenshtein, Tal Gefen
  • Publication number: 20120156227
    Abstract: A protein covalently linked to, or coated with, a non-immunogenic molecule selected from an amino monosaccharide-biotin adduct or a monosaccharide-biotin adduct is disclosed, wherein the coated protein, which has diminished immuno-genicity relative to the uncoated protein and intact biological activity, enables, for example, cross-species vaccination
    Type: Application
    Filed: June 6, 2010
    Publication date: June 21, 2012
    Applicant: GAVISH-GALILEE BIO APPLICATIONS LTD.
    Inventors: Jacob Pitcovski, Jacob Vaya, Soliman Khatib, Alina Aizenshtein, Tal Gefen